These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 2554875)

  • 21. Cardiotonic activity of milrinone, a new and potent cardiac bipyridine, on the normal and failing heart of experimental animals.
    Alousi AA; Canter JM; Montenaro MJ; Fort DJ; Ferrari RA
    J Cardiovasc Pharmacol; 1983; 5(5):792-803. PubMed ID: 6195467
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacology of bipyridine phosphodiesterase III inhibitors.
    Honerjäger P; Nawrath H
    Eur J Anaesthesiol Suppl; 1992; 5():7-14. PubMed ID: 1600969
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An analysis of the mechanism of the inotropic action of some milrinone analogues in guinea-pig isolated atria.
    Dorigo P; Gaion RM; Belluco P; Mosti L; Borea PA; Maragno I
    Br J Pharmacol; 1991 Dec; 104(4):867-72. PubMed ID: 1810600
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro pharmacology of R 80122, a novel phosphodiesterase inhibitor.
    Wilhelm D; Wilffert B; Janssens WJ; Leidig A; Meuter C; Ebbert M; Peters T
    J Cardiovasc Pharmacol; 1992; 20(5):705-14. PubMed ID: 1280731
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of cyclic AMP-dependent protein kinase activity by the cardiotonic drugs amrinone and milrinone.
    Earl CQ; Linden J; Weglicki WB
    Life Sci; 1986 Nov; 39(20):1901-8. PubMed ID: 2430162
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of MS-857, a new and potent cardiotonic agent, in isolated mammalian cardiac muscles.
    Kamiya J; Maruyama M; Kawai K; Kobari T
    J Cardiovasc Pharmacol; 1989 Nov; 14(5):790-7. PubMed ID: 2481195
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Milrinone decreases the positive inotropic response of heart muscle to izadrin].
    Bardamova IB; Afanas'ev SA
    Eksp Klin Farmakol; 1994; 57(4):29-31. PubMed ID: 7950778
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Positive inotropic and vasodilating effects of amrinone and milrinone in isolated canine heart.
    Sys SU; Boels PJ; Brutsaert DL
    J Cardiovasc Pharmacol; 1987 Oct; 10(4):445-9. PubMed ID: 2444798
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of cAMP- and cGMP-dependent protein kinases in the cardiac actions of the new calcium sensitizer, levosimendan.
    Haikala H; Kaheinen P; Levijoki J; Lindén IB
    Cardiovasc Res; 1997 Jun; 34(3):536-46. PubMed ID: 9231037
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Does the positive inotropic action of a novel cardiotonic agent, MCI-154, involve mechanisms other than cyclic AMP?
    Kitada Y; Narimatsu A; Suzuki R; Endoh M; Taira N
    J Pharmacol Exp Ther; 1987 Nov; 243(2):639-45. PubMed ID: 2824754
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Different mechanisms involved in the positive inotropic effects of benzimidazole derivative UD-CG 115 BS (pimobendan) and its demethylated metabolite UD-CG 212 Cl in canine ventricular myocardium.
    Endoh M; Shibasaki T; Satoh H; Norota I; Ishihata A
    J Cardiovasc Pharmacol; 1991 Mar; 17(3):365-75. PubMed ID: 1711596
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of reduced myocardial cyclic AMP content on the response to milrinone in the isolated guinea pig heart.
    Kehler CH; Hebl JR; Soule CL; Gallagher WJ; Houlton AJ
    J Heart Lung Transplant; 1997 Jun; 16(6):636-42. PubMed ID: 9229294
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro characterization of the effects of MCI-154, a novel cardiotonic agent, on cardiac tissues.
    Narimatsu A; Kitada Y; Satoh N; Morita M; Muroyama A; Kobayashi M; Ohizumi Y
    Jpn J Pharmacol; 1989 Mar; 49(3):397-405. PubMed ID: 2545964
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Deficient production of cyclic AMP: pharmacologic evidence of an important cause of contractile dysfunction in patients with end-stage heart failure.
    Feldman MD; Copelas L; Gwathmey JK; Phillips P; Warren SE; Schoen FJ; Grossman W; Morgan JP
    Circulation; 1987 Feb; 75(2):331-9. PubMed ID: 2433073
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacology of bipyridine phosphodiesterase III inhibitors.
    Honerjäger P
    Am Heart J; 1991 Jun; 121(6 Pt 2):1939-44. PubMed ID: 1852089
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Subsensitivity of the failing human heart to isoprenaline and milrinone is related to beta-adrenoceptor downregulation.
    Böhm M; Diet F; Feiler G; Kemkes B; Kreuzer E; Weinhold C; Erdmann E
    J Cardiovasc Pharmacol; 1988 Dec; 12(6):726-32. PubMed ID: 2467092
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A new milrinone analog: role of binding to A1 adenosine receptor in its positive inotropic effect on isolated guinea pig and rat atria.
    Floreani M; Borea PA; Gessi S; Mosti L; Fossa P; Dorigo P
    J Pharmacol Exp Ther; 1997 Nov; 283(2):541-7. PubMed ID: 9353368
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of cyclic nucleotide phosphodiesterase isoenzymes in rat and rabbit ventricular myocardium: positive inotropic and phosphodiesterase inhibitory effects of Org 30029, milrinone and rolipram.
    Shahid M; Nicholson CD
    Naunyn Schmiedebergs Arch Pharmacol; 1990 Dec; 342(6):698-705. PubMed ID: 1710786
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Inotropic effect of novel domestic cardiotonic agent, vesnarinone--test in vitro].
    Han W; Qin Y; Zhang Z; Zhou S; Yang Z
    Hua Xi Yi Ke Da Xue Xue Bao; 1994 Sep; 25(3):316-20. PubMed ID: 7896252
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of milrinone on myocardial mechanical function and cyclic AMP content in the fetal rabbit.
    Ogawa S; Nakanishi T; Kamata K; Takao A
    Pediatr Res; 1987 Sep; 22(3):282-5. PubMed ID: 2443896
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.